Silymarin, Olibanum, and Nettle, A Mixed Herbal Formulation in the Treatment of Type II Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial.
Nahid KhaliliReza FereydoonzadehReza MohtashamiSaeed MehrzadiMojtaba HeydariHasan Fallah HuseiniPublished in: Journal of evidence-based complementary & alternative medicine (2017)
Silybum marianum (L) Gaertn (milk thistle) seeds, Urtica dioica L (nettle) leaves, and Boswellia serrata (olibanum gum) resin are used traditionally by Iranian diabetic patients. The aim of this study was to evaluate the antihyperglycemic effects of these herbs in an herbal formulation in patients with type II diabetes mellitus. Sixty patients diagnosed as type II diabetes mellitus with fasting blood glucose level from 150 to 180 mg/dL, glycosylated hemoglobin level from 7.5% to 8.5%, and on oral antihyperglycemic drugs, were allocated to receive the mix herbal formulation or placebo for 90 days in a double-blind randomized placebo-controlled clinical trial. The mean serum fasting blood glucose, glycosylated hemoglobin, and triglyceride in the herbal drug group were significantly less than placebo group's values after 3 months of the intervention. The study showed a potential antihyperglycemic and triglyceride lowering effect of the herbal formulation, while it did not have any significant cholesterol or blood pressure lowering effect.
Keyphrases
- double blind
- blood glucose
- placebo controlled
- clinical trial
- glycemic control
- phase iii
- phase ii
- blood pressure
- type diabetes
- drug delivery
- study protocol
- phase ii study
- open label
- newly diagnosed
- end stage renal disease
- insulin resistance
- chronic kidney disease
- randomized controlled trial
- climate change
- emergency department
- heart rate
- metabolic syndrome
- human health
- risk assessment
- adipose tissue
- radiation therapy
- skeletal muscle
- peritoneal dialysis